13.06.2013 • NewsMarathon OilMarathonExxonMobil

Marathon Oil Taps Exxon Mobil Executive as next CEO

Marathon Oil has tapped an Exxon Mobil executive to become its next CEO when Clarence Cazalot retires at the end of the year.

Lee Tillman, Exxon Mobil's vice president of engineering, will take the top post at the energy exploration company in January 2014, Marathon Oil said on Thursday.

Tillman's experience in some of the world's most complex energy fields, including Norway, Scotland and Indonesia, will help Marathon Oil as it works to expand its operations in Canada's oil sands, America's shale fields, and in Iraq and Angola.

Tillman, 51, has worked at Exxon Mobil since 1989 after earning a Ph.D. at Auburn University. A chemical engineer by training, he is a car enthusiast and once said in an interview that as a child, he dreamed of racing Formula 1 cars.

Tillman will join Marathon Oil on Aug. 1 as president and Cazalot, 62, will stay on as executive chairman through the end of the year.

It was not immediately clear if Tillman will remain at Exxon Mobil through August. Exxon Mobil declined to comment.

Dennis Reilley, Marathon Oil's current lead director, will be nominated to become non-executive chairman once Cazalot retires, the company said.

In 2011, Houston-based Marathon Oil spun off its refining unit into Marathon Petroleum.

 

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read